Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Biotech to Launch Preclinical Studies of Antibody in Eight Cancer Types

This company's new trials, preferred dosing and upcoming biologics license application submission are discussed in an H.C. Wainwright & Co. report. In a Feb. 20 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that CytoDyn Inc. (CYDY:OTCQB) plans to...
Streetwise Reports | March 1, 2019 |

Doctor Copper Strikes – A True Economic Barometer

Copper has long been an excellent proxy for global economic health. It’s used in everything from washing machines to electric cars. That’s why copper is often referred to as “Doctor Copper” – because it c...
Marin Katusa | January 31, 2020 |

Visionary Vicissitude

It was one of those days that all sexagenarians loathe; you have to go to the doctor, and whether it's the GP (general practitioner) or the dentist or the proctologist, nothing reminds you more rapidly of your advancing age than going to the optometrist. Now, many of ...
Streetwise Reports | January 14, 2020 |

MMT is a spectacularly Dem idea

Economists are good for one thing, and that is creating theories. The trouble is, those theories are often wrong. This is why economics is often called “the dismal science”. Such is the case with the latest economic soup-de-jour, Modern Monetary Theory, o...
Richard (Rick) Mills | April 12, 2019 |

Something Wicked This Way Comes

Ill winds mark its fearsome flight, And autumn branches creak with fright. The landscape turns to ashen crumbs, When something wicked this way comes... (Ray Bradbury) There is a certain maneuver in military strategy that involves the act of conve...
Streetwise Reports | September 25, 2019 |

Cypress Development Corp. (TSX.V:CYP) Clayton Valley Lithium Project versus Chinese LCE/ EV ...

Cypress Development Corp. (TSX.V:CYP) Clayton Valley Lithium Project versus Chinese LCE/ EV battery supply The pause in industrial activity brought about by the covid-19 crisis has led us to a fork in the road with respect to the direction we as a society take in ...
Richard (Rick) Mills | May 19, 2020 |

Cypress Development's Clayton Valley Lithium Project vs. Chinese LCE/EV Battery Supply

The pause in industrial activity brought about by the Covid-19 crisis has led us to a fork in the road with respect to the direction we as a society take in fulfilling the twin mandates of suppressing global warming and growing the economy in challenging times. To some ...
Streetwise Reports | May 22, 2020 |